The options have an exercise price of $97.82 per share, which is equal to the closing price of Sarepta's common stock on March 31, 2020 (the “Grant Date”). Sarepta Therapeutics, Inc. (SRPT) Interactive Stock Chart ... The options have an exercise price of $97.82 per share, which is equal to the closing price of Sarepta's common stock on March 31, 2020 (the “Grant Date”). Sarepta Therapeutics, Inc. (SRPT) Stock Price, Quote ... The employees received, in the aggregate, options to purchase 37,905 shares of Sarepta's common stock, and in the aggregate, 4,025 restricted stock units (“RSUs”). The options have an exercise price of $114.47 per share, which is equal to the closing price of Sarepta's common stock on February 28, 2020 (the “Grant Date”).
Discover historical prices for SRPT stock on Yahoo Finance. View daily, weekly or monthly formats back to when Sarepta Therapeutics, Inc. stock was issued. SRPT Sarepta Therapeutics Inc. — Stock Price and ... Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Sarepta Therapeutics, Inc. (SRPT) Interactive Stock Chart ...
Dec 16, 2019 · The average price target is $204, providing further upside of 55%, should the target be met over the next 12 months. (See Sarepta stock analysis on … Sarepta Therapeutics, Inc. (SRPT) interactive stock chart ... The employees received, in the aggregate, options to purchase 24,310 shares of Sarepta's common stock, and in the aggregate, 12,175 restricted stock units (“RSUs”). The options have an exercise price of $115.96 per share, which is equal to the closing price of Sarepta's common stock on January 31, 2020 (the “Grant Date”). Sarepta Therapeutics, Inc. (SRPT) stock forum & discussion ... from SRPT 2020 10-K; In February 2020, Roche and Roche Finance Ltd, an affiliate of Roche (“Roche Finance”), together paid us an up-front payment of $1.2 billion, comprised of $750.0 million in cash from Roche and approximately $400.0 million from Roche Finance in exchange for 2,522,227 shares of our common stock, priced at $158.59 per SRPT interactive stock chart | Sarepta Therapeutics, Inc ... Australian finance news, stock quotes, currency information and blogs
Sarepta Therapeutics, Inc. (SRPT) stock price, quote ... Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sarepta Therapeutics, Inc. (SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on February 28, 2020 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material Sarepta Therapeutics, Inc. (SRPT) Stock ... - Yahoo Finance Find the latest Sarepta Therapeutics, Inc. (SRPT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Symbol Lookup from Yahoo Finance
Nov 09, 2019 · Sarepta Therapeutics Inc. analyst estimates by MarketWatch. View SRPT revenue estimates and earnings estimates, as well as analyst recommendations.